Comoros vs Maldives: HIV/AIDS deaths averted by antiretroviral therapy
Comoros
7.94 deaths
in 2024
Maldives
2.78 deaths
in 2024
Comoros rank
154th
Maldives rank
157th
HIV/AIDS deaths averted by antiretroviral therapy over time
- Comoros
- Maldives
How they compare
Comoros currently reports 7.94 deaths against 2.78 deaths in Maldives, a difference of 5.16 deaths.
That makes Comoros's figure about 2.9 times Maldives's.
The two have swapped places 1 time across 35 shared years of data; in 1990 it was Maldives ahead.
Comoros ranks 154th and Maldives ranks 157th of 157 countries.
Across the 4 decades both report, Comoros averaged higher in 2 and Maldives in 1.
Head to head by decade
| Decade | Comoros | Maldives | Difference | Ahead |
|---|---|---|---|---|
| 1990s | 0 deaths | 0 deaths | 0 deaths | — |
| 2000s | 0 deaths | 0.2266 deaths | 0.2266 deaths | Maldives |
| 2010s | 4.45 deaths | 1.11 deaths | 3.34 deaths | Comoros |
| 2020s | 7.51 deaths | 2.3 deaths | 5.2 deaths | Comoros |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher hiv/aids deaths averted by antiretroviral therapy, Comoros or Maldives?
- Comoros, at 7.94 deaths against 2.78 deaths in Maldives as of 2024.
- What is the difference in hiv/aids deaths averted by antiretroviral therapy between Comoros and Maldives?
- 5.16 deaths, with Comoros ahead.
- How many years of comparable data are there for Comoros and Maldives?
- 35 years are reported by both, from 1990 to 2024.
- How do Comoros and Maldives rank globally for hiv/aids deaths averted by antiretroviral therapy?
- Comoros ranks 154th and Maldives ranks 157th of 157 countries.
- Where does this data come from?
- Joint United Nations Programme on HIV/AIDS (2026) – with minor processing by Our World in Data, published as HIV/AIDS deaths averted by antiretroviral therapy. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Number of deaths prevented as a direct result of Antiretroviral Therapy (ART) among people living with HIV. It is calculated by comparing the observed mortality rates in individuals receiving ART to the estimated mortality rates in the absence of such treatment. This is the central estimate.